← FDA Drug Approvals (Drugs@FDA)

ENSTILAR

NDA · New Drug Application · Sponsor: LEO PHARMA AS · Approved 2015-10-16

Drug application

FDA Application #

NDA207589

Application type

New Drug Application

Brand name

ENSTILAR

Generic name

CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE

Active ingredients

BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE

Dosage form

AEROSOL, FOAM

Route

TOPICAL

Marketing status

Prescription

Sponsor

LEO PHARMA AS

Manufacturer

LEO Pharma Inc.

First approval

2015-10-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown